Commercial Launch of Keuro Cyllene® Intracranial Vascular Stent

Against a promising industry backdrop, China’s neurointervention sector has secured another major breakthrough. Cyllene® Intracranial Vascular Stent, independently developed by Keuro Technology, has officially launched commercial supply upon obtaining the Class III medical device registration certificate from the National Medical Products Administration (NMPA).

This achievement represents Keuro Technology’s pivotal advancement in high-end neurointerventional therapy. It offers premium domestic treatment solutions for patients with intracranial aneurysms and contributes substantially to the development of China’s high-end intelligent medical manufacturing.